Cognitive Function in a Randomized Trial of Evolocumab von Giugliano, Robert P, Mach, François, Zavitz, Kenton, Kurtz, Christopher, Im, Kyungah, Kanevsky, Estella, Schneider, Jingjing, Wang, Huei, Keech, Anthony, Pedersen, Terje R, Sabatine, Marc S, Sever, Peter S, Robinson, Jennifer G, Honarpour, Narimon, Wasserman, Scott M, Ott, Brian R

Volltext

Inclisiran in primary prevention: reality or fiction? von Gencer, Baris, Mach, François

Volltext

Potential of Lipoprotein(a)-Lowering Strategies in Treating Coronary Artery Disease von Gencer, Baris, Mach, François

Volltext

Lipoprotein(a): the revenant von Gencer, Baris, Kronenberg, Florian, Stroes, Erik S, Mach, François

Volltext

So low… so far so good: neurocognitive impact of lowering LDL-C levels with PCSK9 inhibitors von Gencer, Baris, Mach, François

Volltext

Air pollution triggers inflammation and cardiovascular events: now is the time to act von Gencer, Baris, Mach, Francois

Volltext

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia von Santos, Raul D, Ruzza, Andrea, Hovingh, G. Kees, Wiegman, Albert, Mach, François, Kurtz, Christopher E, Hamer, Andrew, Bridges, Ian, Bartuli, Andrea, Bergeron, Jean, Szamosi, Tamás, Santra, Saikat, Stefanutti, Claudia, Descamps, Olivier S, Greber-Platzer, Susanne, Luirink, Ilse, Kastelein, John J.P, Gaudet, Daniel

Volltext

Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure von Gencer, Baris, Bonomi, Marco, Adorni, Maria Pia, Sirtori, Cesare R., Mach, François, Ruscica, Massimiliano

Volltext

Lipoprotein(a): the perpetual supporting actor von Gencer, Baris, Mach, François

Volltext

The specific role of chemokines in atherosclerosis von Braunersreuther, Vincent, Mach, François, Steffens, Sabine

Volltext

Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials von Koskinas, Konstantinos C, Siontis, George C M, Piccolo, Raffaele, Mavridis, Dimitris, Räber, Lorenz, Mach, François, Windecker, Stephan

Volltext

The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury von Steffens, Sabine, Montecucco, Fabrizio, Mach, François

Volltext

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial von Giugliano, Robert P, Pedersen, Terje R, Park, Jeong-Gun, De Ferrari, Gaetano M, Gaciong, Zbigniew A, Ceska, Richard, Toth, Kalman, Gouni-Berthold, Ioanna, Lopez-Miranda, Jose, Schiele, François, Mach, François, Ott, Brian R, Kanevsky, Estella, Pineda, Armando Lira, Somaratne, Ransi, Wasserman, Scott M, Keech, Anthony C, Sever, Peter S, Sabatine, Marc S

Volltext

Pathophysiological role of neutrophils in acute myocardial infarction von Carbone, Federico, Nencioni, Alessio, Mach, François, Vuilleumier, Nicolas, Montecucco, Fabrizio

Volltext

Role of Matrix Metalloproteinase-8 in Atherosclerosis von Lenglet, Sébastien, Mach, François, Montecucco, Fabrizio

Volltext

Statins as immunomodulatory agents von Mach, François

Volltext

Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) von Koskinas, Konstantinos C., Windecker, Stephan, Pedrazzini, Giovanni, Mueller, Christian, Cook, Stéphane, Matter, Christian M., Muller, Olivier, Häner, Jonas, Gencer, Baris, Crljenica, Carmela, Amini, Poorya, Deckarm, Olga, Iglesias, Juan F., Räber, Lorenz, Heg, Dik, Mach, François

Volltext

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk: Insights From the FOURIER Trial von O’Donoghue, Michelle L, Fazio, Sergio, Giugliano, Robert P, Stroes, Erik S.G, Kanevsky, Estella, Gouni-Berthold, Ioanna, Im, KyungAh, Lira Pineda, Armando, Wasserman, Scott M, Češka, Richard, Ezhov, Marat V, Jukema, J Wouter, Jensen, Henrik K, Tokgözoğlu, S Lale, Mach, François, Huber, Kurt, Sever, Peter S, Keech, Anthony C, Pedersen, Terje R, Sabatine, Marc S

Volltext

Lipid management in ACS: Should we go lower faster? von Gencer, Baris, Mach, François

Volltext

A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice von Braunersreuther, Vincent, Steffens, Sabine, Arnaud, Claire, Pelli, Graziano, Burger, Fabienne, Proudfoot, Amanda, Mach, François

Volltext